Animation Education Program Applied to Laparoscopic Sleeve Gastrectomy Patients

Surgery Clinical Trial

Official title:

Animation Education Program Applied to Laparoscopic Sleeve Gastrectomy Patients Effect on Patient Care Results: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05251857
• Other study ID #: AEP16
• Status: Completed
• Phase: N/A
• Start date: February 1, 2020
• Est. completion date: June 15, 2021

Study information

• Verified date: May 2022
• Source: Ataturk University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Objectives This study investigated the effect of animation education developed for respiratory rehabilitation among sleeve gastrectomy patients on patient care results.

Design This is a randomized controlled study. Method A total of 66 patients who were going to have sleeve gastrectomy were randomly divided into two groups each including 33 participants. The intervention group was provided with animation education. The control group received routine face-to-face education. Postoperative risk of respiratory complications, presence of dyspnea, nausea, and vomiting, frequency of postoperative respiratory exercises, and satisfaction with postoperative respiratory education were examined. Patients' pain and sleep quality were examined one day before the surgery and on the postoperative first and fifth days.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 66
• Est. completion date: June 15, 2021
• Est. primary completion date: June 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

The patients,

who are in clinical treatment for sleeve gastrectomy; who are 18 years of age or older, mentally healthy; who can speak and understand Turkish; who owns and can use smartphones; who do not have chronic diseases related to the respiratory system (lung diseases, etc.); who are volunteers, will be included in the study.

Exclusion Criteria:

The Patients

who are a lung infection in the last month who are neurological disease who are major psychiatric diagnosis who are vision and hearing problems who are intolerable dyspnea who do not agree to participate in the study, will be excluded

Related Conditions & MeSH terms

• Educational Problems
• Surgery

Intervention

Behavioral:
• Animation Education Program Applied to Laparoscopic Sleeve Gastrectomy Patients
Behavioral: Animation Education Program The investigators will apply Animation Education Program.

Locations

Country	Name	City	State
Turkey	Ataturk University	Erzurum

Sponsors (1)

Lead Sponsor	Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analog Scale	Pain levels Visual Analog Scale (VAS): The VAS was used to evaluate the severity of pain in patients. VAS is a 10 cm ruler that shows no pain on one edge and unbearable pain on the other edge. Therefore, patients are asked to evaluate their pain between 0 "no pain" and 10 "unbearable pain." They show the severity of their pain using a sign on that ruler. The point indicated by the patient is recorded from the starting point of 0. VAS is an understandable and easily applicable scale to evaluate the pain levels of patients	until the treatment is completed,an average of 5 days
Primary	Richard Campbell Sleep Questionnaire (RCSQ)	Sleep quality Richard Campbell Sleep Questionnaire (RCSQ) The scale was developed by Richards in 1987. Its Turkish validity and reliability study was conducted by Özlü and Özer in 2015. RCSQ evaluates the depth of night sleep, time to fall asleep, frequency of awakening, time awake when awakened, sleep quality, and the noise level in the environment. The scale consists of 6 questions. Each item is scored between 0 and 100 using the VAS. A score of 0-25 points obtained from the scale indicates very bad sleep and 76-100 indicates very good sleep.	until the treatment is completed,an average of 5 days
Secondary	Respiratory complications question form	respiratory complications	until the treatment is completed,an average of 5 days